PERSANTINE

This brand name is authorized in United States. It is also authorized in Canada, France.

Active ingredients

The drug PERSANTINE contains one active pharmaceutical ingredient (API):

1	Dipyridamole UNII 64ALC7F90C - DIPYRIDAMOLE
	Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation.
	Read more about Dipyridamole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PERSANTINE Coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC07	Dipyridamole	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00637734
FR	Base de données publique des médicaments	60021216, 68572748
US	FDA, National Drug Code	0597-0017, 0597-0018, 0597-0019